Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
11 04 2023
Historique:
accepted: 07 02 2023
revised: 01 02 2023
received: 12 10 2022
medline: 12 4 2023
pubmed: 4 3 2023
entrez: 3 3 2023
Statut: ppublish

Résumé

Acne vulgaris is a chronic disfiguring skin disease affecting ∼1 billion people worldwide, often having persistent negative effects on physical and mental health. The Gram-positive anaerobe, Cutibacterium acnes is implicated in acne pathogenesis and is, therefore, a main target for antibiotic-based acne therapy. We determined a 2.8-Å resolution structure of the 70S ribosome of Cutibacterium acnes by cryogenic electron microscopy and discovered that sarecycline, a narrow-spectrum antibiotic against Cutibacterium acnes, may inhibit two active sites of this bacterium's ribosome in contrast to the one site detected previously on the model ribosome of Thermus thermophilus. Apart from the canonical binding site at the mRNA decoding center, the second binding site for sarecycline exists at the nascent peptide exit tunnel, reminiscent of the macrolides class of antibiotics. The structure also revealed Cutibacterium acnes-specific features of the ribosomal RNA and proteins. Unlike the ribosome of the Gram-negative bacterium Escherichia coli, Cutibacterium acnes ribosome has two additional proteins, bS22 and bL37, which are also present in the ribosomes of Mycobacterium smegmatis and Mycobacterium tuberculosis. We show that bS22 and bL37 have antimicrobial properties and may be involved in maintaining the healthy homeostasis of the human skin microbiome.

Identifiants

pubmed: 36864821
pii: 7067950
doi: 10.1093/nar/gkad103
pmc: PMC10085706
doi:

Substances chimiques

Anti-Bacterial Agents 0
sarecycline 94O110CX2E
Tetracyclines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2915-2930

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Sci Rep. 2020 Apr 1;10(1):5754
pubmed: 32238884
Mol Cell. 2002 Jul;10(1):117-28
pubmed: 12150912
Int J Biomed Sci. 2005 Jun;1(1):2-7
pubmed: 18074004
Nat Chem Biol. 2020 Oct;16(10):1071-1077
pubmed: 32601485
Nat Struct Mol Biol. 2015 Jun;22(6):466-9
pubmed: 25984972
Medchemcomm. 2018;9:12-21
pubmed: 29527285
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8191-8196
pubmed: 30038002
J Pathol. 2011 Oct;225(2):285-92
pubmed: 21706477
Nucleic Acids Res. 2018 Feb 28;46(4):1973-1983
pubmed: 29390134
Microbiology (Reading). 2021 Feb;167(2):
pubmed: 33555244
Front Microbiol. 2021 Jun 28;12:682682
pubmed: 34262544
Nat Rev Microbiol. 2018 Mar;16(3):143-155
pubmed: 29332945
EMBO J. 2010 Sep 15;29(18):3108-17
pubmed: 20676057
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10496-501
pubmed: 21670252
Science. 2006 Sep 29;313(5795):1935-42
pubmed: 16959973
RNA Biol. 2017 Nov 2;14(11):1514-1521
pubmed: 28440695
Cell Rep. 2017 Jul 5;20(1):149-160
pubmed: 28683309
J Mol Biol. 2006 Jul 21;360(4):893-906
pubmed: 16784753
Nat Commun. 2021 Jul 22;12(1):4466
pubmed: 34294725
Dermatol Ther. 2020 Nov;33(6):e14252
pubmed: 32860489
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Cell. 2005 Jan 14;120(1):49-58
pubmed: 15652481
Mol Cell. 2021 Jun 17;81(12):2566-2582.e6
pubmed: 33878294
Biol Chem. 2014 May;395(5):559-75
pubmed: 24497223
Antibiotics (Basel). 2021 Apr 15;10(4):
pubmed: 33920812
J Cell Physiol. 2021 Mar;236(3):2214-2225
pubmed: 32783256
Science. 2005 Nov 4;310(5749):827-34
pubmed: 16272117
Cell Rep. 2017 Jul 18;20(3):521-528
pubmed: 28723557
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3812-6
pubmed: 23431179
J Bacteriol. 2021 Apr 21;203(10):
pubmed: 33649148
Nature. 2013 Aug 15;500(7462):307-11
pubmed: 23873042
Med Mal Infect. 2014 Jun;44(6):241-50
pubmed: 24656842
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):
pubmed: 27527699
Nat Struct Mol Biol. 2009 May;16(5):528-33
pubmed: 19363482
Nucleic Acids Res. 2021 Jan 11;49(1):547-567
pubmed: 33330920
Elife. 2016 Jul 19;5:
pubmed: 27434674
Br J Dermatol. 2013 Mar;168(3):474-85
pubmed: 23210645
BMC Bioinformatics. 2016 Mar 22;17:135
pubmed: 27000765
Eur J Biochem. 1981 Sep 1;118(3):615-9
pubmed: 7028483
mBio. 2021 Jun 29;12(3):e0103121
pubmed: 34044590
Cold Spring Harb Perspect Med. 2016 Sep 01;6(9):
pubmed: 27481773
Br J Dermatol. 2015 Jul;172 Suppl 1:3-12
pubmed: 25597339
Nat Commun. 2021 Jun 22;12(1):3850
pubmed: 34158503
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8188-93
pubmed: 27382179
Structure. 2020 Oct 6;28(10):1087-1100.e3
pubmed: 32857965
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7527-32
pubmed: 27330110
Nat Struct Mol Biol. 2004 Oct;11(10):1008-14
pubmed: 15448679
Biochem Biophys Res Commun. 2004 Apr 16;316(4):978-83
pubmed: 15044080
Phys Biol. 2008 Nov 24;5(4):046005
pubmed: 19029596
Nat Struct Mol Biol. 2020 Oct;27(10):959-966
pubmed: 32908316
J Mol Biol. 2003 Jul 25;330(5):1061-75
pubmed: 12860128
Br J Dermatol. 2022 Apr;186(4):673-683
pubmed: 34758111
Curr Opin Struct Biol. 2014 Feb;24:165-9
pubmed: 24524803
J Clin Microbiol. 2016 Apr;54(4):980-7
pubmed: 26818667
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20530-20537
pubmed: 32817463
Science. 2000 Aug 11;289(5481):905-20
pubmed: 10937989
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Commun Biol. 2020 Feb 6;3(1):58
pubmed: 32029867
Clin Microbiol Rev. 2014 Jul;27(3):419-40
pubmed: 24982315
Mol Cell. 2020 Dec 17;80(6):1055-1066.e6
pubmed: 33188728
Elife. 2020 Sep 14;9:
pubmed: 32924932
Exp Dermatol. 2021 Oct;30(10):1484-1495
pubmed: 34252227
Nat Biotechnol. 2006 Dec;24(12):1551-7
pubmed: 17160061
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30397052
J Phys Chem B. 2011 Feb 17;115(6):1469-84
pubmed: 21254753
Mol Cell. 2008 Apr 25;30(2):190-202
pubmed: 18439898
Lancet. 2012 Jan 28;379(9813):361-72
pubmed: 21880356
Exp Cell Res. 2018 Aug 15;369(2):243-250
pubmed: 29803741
Nat Struct Mol Biol. 2014 Sep;21(9):787-93
pubmed: 25132179
Cell. 2000 Dec 22;103(7):1143-54
pubmed: 11163189
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W5-9
pubmed: 18440982
Nucleic Acids Res. 2016 Dec 1;44(21):10491-10504
pubmed: 27906650
Nucleic Acids Res. 2017 Oct 13;45(18):10884-10894
pubmed: 28977617
Nat Rev Microbiol. 2022 Jul;20(7):431-443
pubmed: 35102308

Auteurs

Ivan B Lomakin (IB)

Department of Dermatology, Yale University School of Medicine, New Haven, CT06520, USA.

Swapnil C Devarkar (SC)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT06520, USA.

Shivali Patel (S)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT06520, USA.

Ayman Grada (A)

Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

Christopher G Bunick (CG)

Department of Dermatology, Yale University School of Medicine, New Haven, CT06520, USA.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT06520, USA.
Program in Translational Biomedicine, Yale University School of Medicine, New Haven, CT 06520, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH